A racemic synthesis of azanoradamantane (± ± ± ±)-3 was accomplished via Yamamoto's MAD-catalyzed Diels-Alder protocol. Subsequently, a scalable asymmetric synthesis of azanoradamantane benzamide SC-52491 was carried out employing Helmchen's asymmetric Diels-Alder methodology to construct all four contiguous asymmetric centers with the correct relative stereochemistry and in 99.3% e.e. Pharmaceutical companies are advancing an increasing number of enantiomerically pure drugs 1 in order to maximize potency and selectivity, and to eliminate the complications which may arise from the presence of a less active or inactive stereoisomer. The asymmetric Diels-Alder 2 reaction is a powerful synthetic method for the construction of non-racemic pharmacologically active agents.
We required a scalable asymmetric synthesis of SC-52491, which contains four contiguous asymmetric centers. Our previous 7 synthetic route (Scheme 1) employed a reductive Pauson-Khand reaction 8 which was ideal for small-scale synthesis, and a late-stage resolution which provided us with both enantiomers for biological evaluation, but these procedures are not easily scalable. The previous synthesis of SC-52491 did employ a very efficient closure to the azanoradamantane ring system [(-)-1 to (+)-2], and we hoped that we could utilize a similar cyclization in our new synthetic strategy. We also wanted to eliminate chlorinated solvents from the synthesis and to simplify or eliminate any chromatographic purifications. We envisioned a new approach based on the retrosynthetic analysis shown in Scheme 2, wherein the azanoradamantane 3 would be formed in one step from a tetrasubstituted cyclopentane 4 via a tandem cyclization involving SN 2 displacement of suitable leaving groups (X) by the primary amine. One of the two cyclizations is the same as the efficient cyclization employed in our previous synthetic approach. The tetrasubstituted cyclopentane 4 would then be derived from oxidative cleavage of a rigid norbornene 5, in which the four contiguous asymmetric centers could be easily defined and prepared via an asymmetric Diels-Alder reaction. 
Scheme 2
We first employed Yamamoto's MAD-catalyzed Diels-Alder reaction 9 to prepare norbornene (± ± ± ±)-7
(Scheme 3). This approach assembles the four requisite stereocenters in their proper relative orientation, albeit in racemic fashion. We originally hoped to employ an early-stage resolution or to employ a chiral Lewis acid catalyst in the Diels-Alder reaction to obtain the correct absolute configuration of the four stereocenters.
Ultimately the Yamamoto approach allowed us to explore various means of installing functionality to provide the bridgehead nitrogen and the amino substituent of aminoazanoradamantane 3. As per Yamamoto's protocol, cyclopentadiene is reacted with tert-butyl methyl fumarate 6 10 with MAD catalysis to afford the Diels-Alder adduct (± ± ± ±)-7 in high yield and excellent diastereoselectivity (98:2). The esters are easily differentiated by cleaving the tert-butyl ester with trifluoroacetic acid to afford carboxylic acid (± ± ± ±)-7. We proceeded from Yamamoto's intermediate (± ± ± ±)-7 with a Curtius rearrangement to install the exo-amino substituent protected as the benzyl carbamate in compound (± ± ± ±)-8. Lithium borohydride reduction gave the endo hydroxymethyl derivative (± ± ± ±)-9. 
Scheme 3
The alcohol (± ± ± ±)-9 was converted to the mesylate (± ± ± ±)-10 in quantitative yield, but the mesylate was unexpectedly resistant toward displacement by azide. Treatment with sodium azide in a variety of solvents, with or without added sodium iodide present in the reaction mixture gave no desired product. Only starting material was observed until the temperature was raised sufficiently for consumption of starting material, at which point the norbornene bicyclic system was also destroyed, presumably via a retro-Diels-Alder reaction.
To overcome this problem, alcohol (± ± ± ±)-9 was oxidized to the aldehyde (± ± ± ±)-12 in 95% yield with no evidence of epimerization. Reductive amination of the aldehyde with ammonium acetate gave the desired primary amine (± ± ± ±)-13, but in consistently low yields, along with significant quantities of secondary amine by-product.
Attempts to optimize the reductive amination of aldehyde (± ± ± ±)-12 were unsuccessful. The amine (± ± ± ±)-13 was protected as the BOC derivative (± ± ± ±)-14. Despite the inefficient reductive amination, sufficient quantities of the BOC-protected amine (± ± ± ±)-14 were obtained to continue validation of the Diels-Alder approach to aminoazanoradamantanes.
Ozonolysis of the norbornene (± ± ± ±)-14 followed by workup with sodium borohydride gave the diol (± ± ± ±)-15
in 27 % yield (Scheme 4). Diol (± ± ± ±)-15 was converted to the azanoradamantane (± ± ± ±)-16 by a sequence involving bis-tosylation, trifluoroacetic acid removal of the BOC protecting group, and subsequent treatment with diisopropylethylamine, as in the conversion of (-)-1 to (+)-2. We were confident at this point that we had obtained the desired azanoradamantane based on spectroscopic analysis, but final confirmation was provided by reductive removal of the benzyl carbamate protecting group to afford the free aminoazanoradamantane (± ± ± ±)-3, which was identical by proton NMR to the chiral material we had obtained by our previous method. The utilization of Yamamoto's racemic acid ester (±)-7 verified the norbornene approach to aminoazanoradamantanes, but we were also still faced with the task of producing non-racemic material. In addition, several steps in the sequence were low yielding and therefore unsuitable for large scale work. Our preliminary attempts at resolution of 5-norbornene-2,3-dicarboxylic acid utilizing chiral bases were not encouraging. Zwanenburg's esterase approach 11 employing dimethyl 5-norbornene-2,3-dicarboxylate is attractive but affords the wrong enantiomer for the production of SC-52491. We were ultimately attracted to the highly efficient asymmetric Diels-Alder reaction reported by Helmchen 2c,12 to prepare the requisite norbornene to serve as an intermediate for the preparation of chiral aminoazanoradamantanes. The synthetic approach to SC-52491 starting with Helmchen's Diels-Alder methodology was realized as outlined in Schemes 5 and 6.
The chiral norbornene diethyl-(S)-lactate ester 18 was prepared via an uncatalyzed Diels-Alder reaction of the corresponding fumarate diethyl-(S)-lactate ester 17 and cyclopentadiene according to Helmchen 2c,12 (Scheme 5). The original procedure reported the use of carbon tetrachloride/hexane (1:3) for this Diels-Alder reaction. Since we did not want to use halogenated solvents on a large scale, particularly not carbon tetrachloride, we examined a number of other solvent systems. All other solvent systems examined gave inferior results (82-90% d.e.), but we found unexpectedly that utilization of triethylamine as a solvent gave the desired diastereomer 18 in 91-95% d.e. The Diels-Alder reaction proceeds smoothly on warming the reaction from -25°C to room temperature. Saponification of 18 and iodolactonization gave the crystalline iodolactone (+)-19 in 63% yield from fumaric ester 17 and in 99.3% e.e. by chiral HPLC. The crystallization of (+)-19 is responsible for the very high e.e. beyond what may be expected from the diastereomeric ratio of 18. The carboxylic acid moiety of (+)-19 was then converted to the primary amide (+)-20 via the acid chloride in 81-96% yield. A Hofmann-type rearrangement was performed utilizing HTIB (hydroxytosyloxy iodobenzene;
Koser's reagent 13 ) to give the primary amine (+)-21. The reaction was driven to completion with the addition of iodobenzene diacetate, which presumably gives rise to the formation of HTIB in situ. Subsequent tosylation gave the tosylamide (-)-22 in high yield. The iodolactone was reductively cleaved with zinc in acetic acid in almost quantitative yield to give the norbornene carboxylic acid (-)-23. 
Scheme 5
Ozonolysis of (-)-23 with a reductive workup employing sodium borohydride followed by acidification of the crude mixture gave the lactone (+)-24 in quantitative yield (Scheme 6). This procedure employing the free carboxylic acid of (-)-23 to enable direct formation of the lactone was an important factor in obtaining high yields in this ozonolysis, in contrast to the poor yield obtained in the conversion of norbornene (± ± ± ±)-14 to diol (± ± ± ±)-15. In addition, the resulting γ-lactone of (+)-24 provided a convenient handle for the incorporation of the amine functionality. Ammonolysis of the lactone gave the primary amide (+)-25. Reduction with borane gave amine 26, which was protected as the tert-butylcarbamate to afford BOC-amine diol (+)-27. Bis-tosylation of the diol was followed directly by removal of the tert-butylcarbamate protecting group with trifluoroacetic acid, and subsequent treatment with diisopropylethylamine in acetonitrile gave the tosyl-protected azanoradamantane (+)-2 7 in 96% yield without the need for purification. Deprotection of the tosylamide proceeded cleanly with calcium metal in liquid ammonia. Calcium was chosen over lithium, which we employed earlier, 7 because of its safer handling characteristics. Coupling of the derived chiral aminoazanoradamantane 3 with 4-amino-5-chloro-2-methoxybenzoic acid utilizing carbonyldiimidazole (CDI) as the coupling reagent gave the desired benzamide in 70% yield, without the use of the acetamide protecting group that was employed in the earlier synthesis. 7 The product of the coupling was sufficiently pure to use after trituration with a minimum amount of ethyl acetate.
The free base was then converted to the crystalline monohydrochloride salt, SC-52491. To a solution of carboxylic acid 7 9 (1.88 g, 9.58 mmol) and triethylamine (1.65 mL, 1.26 g, 12.5 mmol) in acetone (30 mL) at 0°C was added ethyl chloroformate (0.92 mL, 1.0 g, 9.6 mmol) dropwise over several minutes.
After the addition was complete the solution was stirred for 1h at 0°C. A solution of sodium azide (1.87 g, 28.7 mmol) in water (30 mL) was then added and the reaction was stirred for an additional hour at 0°C. The solution was then poured in to ice water and the resulting mixture was extracted with ethyl acetate (4 X 50 mL allowed to stand at 0°C for 23 h. The solution was then poured onto ice (15 g) and extracted with ethyl acetate (3 X 10 mL). The combined organic extracts were washed successively with water (3 X 30 mL) and brine (30 mL) and then dried over sodium sulfate. Concentration gave the di-tosylate (23 mg) as a colorless oil which was treated directly with freshly-distilled trifluoroacetic acid (0.5 mL) at rt. After stirring for 15 min the solution was concentrated in vacuo to give a residue which was redissolved in acetonitrile (1 mL) and treated with diisopropylethylamine (31 mg, 0.24 mmol). After 21 h at rt the solution was concentrated in vacuo to give a residue which was treated with aqueous 15% potassium carbonate (1 mL) and then extracted with chloroform (3 X 15 mL). The combined organic extracts were washed successively with water and brine and then dried over sodium sulfate. Concentration then gave the title azanoradamantane (± ± ± ±)-16 ( Hz), 1.3 (6H, t, J=12 Hz). Alder adduct (18) . In a modification of Helmchen's 2c procedure, di-(ethyl (S)-lactate) fumarate 17 (352 g, 1.11 mol) was dissolved in 5.5 liters of Et 3 N and cooled to 0°C. Cyclopentadiene (140 mL; 1.71 mol) was added within ten minutes, and the reaction was mildly exothermic. The temperature reached 8°C before dropping again to 0°C. The reaction mixture was allowed to warm to room temperature and stir for 18 h. Amine 26. To a suspension of primary amide 25 (1.0 g, 2.9 mmol) in THF (100 mL) was added dropwise a 1M solution of borane-THF over 20 min. The reaction mixture stirred for 1 h at rt followed by refluxing for 18 h.
Diels-
The reaction mixture was cooled to 0°C and 15% aqueous HCl (100 mL) was added. The reaction was then allowed to warm up to stir at rt for 14 h The solution was then concentrated in vacuo to a white foam which was dissolved in water (10 mL) and then treated with 1N NaOH (10 mL 20°C was added p-toluenesulfonyl chloride (369 mg, 1.94 mmol) with stirring. After dissolution was complete the solution was allowed to stand at 0°C for 21 h. The reaction was then poured onto ice and extracted with ethyl acetate (3X). The combined extracts were washed successively with water (5X) and brine and then dried over sodium sulfate. Concentration gave a colorless foam (357 mg). The foam was dissolved in trifluoroacetic acid (5 mL) and allowed to stand for 15 min at rt after which time the reaction was concentrated under vacuum.
The resulting residue was dissolved in acetonitrile (10 mL) and treated with diisopropylethylamine (433 mg, 3.35 mmol). After 4 days at rt the pale yellow solution was warmed to 46°C for 2h. Concentration gave a residue which was treated with 4N KOH/presaturated with NaCl (5 mL) and extracted with ethyl acetate (5X).
The combined extracts were washed with water (2X) and brine and dried over sodium sulfate. Concentration then gave the tosylamide azanoradamantane (+)-2 (134 mg, 96%) as a pale yellow solid: mp 203-205°C; [α] D = +3.0° (c = 0.76 in CHCl 3 ). The proton NMR was identical to the material prepared via the previously described route. 7
Hexahydro-2,5β β β β-methano-1H-3aS,3aα α α α,6aα α α α-cyclopehta[c]pyrrol-4α α α α-amine (3). To liquid ammonia (30 mL) at -33°C was added a solution of tosylamide (+)-2 (539 mg, 1.84 mmol) in THF (7 mL). Calcium metal (319 mg, 7.96 mmol) was added in three portions over 5 min. After 30 min the dark blue reaction was quenched with addition of solid ammonium chloride (985 mg, 18.4 mmol). Concentration gave a residue which was treated with 4N KOH-presaturated with NaCl (9.2 mL). The suspension was filtered through celite and the solid was washed with THF. The filtrate was extracted with THF (7X) and the combined THF rinses and extracts were dried over sodium sulfate. Concentration gave chiral aminoazanoradamantane 3 (0.29 g, 100%) as a colorless waxy solid. The proton NMR was identical to the material prepared via the previously described route. 7 Found: C, 50.80; H, 6.16; N, 11.00; Cl, 18.54. The proton NMR was identical to the material prepared via the previously described route. 7 
